DE3230299A1 - Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung - Google Patents

Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Info

Publication number
DE3230299A1
DE3230299A1 DE19823230299 DE3230299A DE3230299A1 DE 3230299 A1 DE3230299 A1 DE 3230299A1 DE 19823230299 DE19823230299 DE 19823230299 DE 3230299 A DE3230299 A DE 3230299A DE 3230299 A1 DE3230299 A1 DE 3230299A1
Authority
DE
Germany
Prior art keywords
cea
column
fraction
buffer
fractions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823230299
Other languages
German (de)
English (en)
Inventor
Rolf Prof. Dr. 8000 München Lamerz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE19823230299 priority Critical patent/DE3230299A1/de
Priority to EP83107954A priority patent/EP0102008A3/de
Priority to DD83253901A priority patent/DD211714A5/de
Priority to FI832899A priority patent/FI832899L/fi
Priority to IL69476A priority patent/IL69476A0/xx
Priority to PT77199A priority patent/PT77199B/pt
Priority to NO832905A priority patent/NO832905L/no
Priority to ES524909A priority patent/ES524909A0/es
Priority to AU17960/83A priority patent/AU1796083A/en
Priority to ZA835947A priority patent/ZA835947B/xx
Priority to GR72215A priority patent/GR78692B/el
Priority to DK368783A priority patent/DK368783A/da
Priority to JP58146758A priority patent/JPS5950360A/ja
Publication of DE3230299A1 publication Critical patent/DE3230299A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19823230299 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung Withdrawn DE3230299A1 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung
EP83107954A EP0102008A3 (de) 1982-08-14 1983-08-11 Carcinoembryonales Antigen, Verfahren zu seiner Isolierung und seine Verwendung
DD83253901A DD211714A5 (de) 1982-08-14 1983-08-11 Verfahren zur isolierung von carcinoembryonalem antigen
FI832899A FI832899L (fi) 1982-08-14 1983-08-11 Karcinoembryonal antigen, foerfarande foer dess isolering och dess anvaendning
IL69476A IL69476A0 (en) 1982-08-14 1983-08-12 Carcinoembryonic antigen,a process for its isolation and its use
PT77199A PT77199B (de) 1982-08-14 1983-08-12 Carcinoembryonales antigen verfahren zu seiner isolierung und seine verwendung
NO832905A NO832905L (no) 1982-08-14 1983-08-12 Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse
ES524909A ES524909A0 (es) 1982-08-14 1983-08-12 Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo
AU17960/83A AU1796083A (en) 1982-08-14 1983-08-12 Carcinoembryonic antigen
ZA835947A ZA835947B (en) 1982-08-14 1983-08-12 Carcinoembryonal antigen,a process for its isolation and its use
GR72215A GR78692B (OSRAM) 1982-08-14 1983-08-12
DK368783A DK368783A (da) 1982-08-14 1983-08-12 Carcinoembryonalt antigen, fremgangsmaade til dets isolering og dets anvendelse
JP58146758A JPS5950360A (ja) 1982-08-14 1983-08-12 癌胚抗原およびその単離方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Publications (1)

Publication Number Publication Date
DE3230299A1 true DE3230299A1 (de) 1984-02-16

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823230299 Withdrawn DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Country Status (13)

Country Link
EP (1) EP0102008A3 (OSRAM)
JP (1) JPS5950360A (OSRAM)
AU (1) AU1796083A (OSRAM)
DD (1) DD211714A5 (OSRAM)
DE (1) DE3230299A1 (OSRAM)
DK (1) DK368783A (OSRAM)
ES (1) ES524909A0 (OSRAM)
FI (1) FI832899L (OSRAM)
GR (1) GR78692B (OSRAM)
IL (1) IL69476A0 (OSRAM)
NO (1) NO832905L (OSRAM)
PT (1) PT77199B (OSRAM)
ZA (1) ZA835947B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6022958A (en) * 1986-08-13 2000-02-08 Bayer Corporation cDNAs coding for members of the carcinoembryonic antigen family
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
ZA835947B (en) 1984-04-25
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DK368783A (da) 1984-02-15
AU1796083A (en) 1985-02-21
FI832899A7 (fi) 1984-02-15
PT77199B (de) 1986-03-27
EP0102008A3 (de) 1987-01-28
JPS5950360A (ja) 1984-03-23
GR78692B (OSRAM) 1984-09-27
ES8404187A1 (es) 1984-05-01
FI832899L (fi) 1984-02-15
NO832905L (no) 1984-02-15
FI832899A0 (fi) 1983-08-11
IL69476A0 (en) 1983-11-30
DK368783D0 (da) 1983-08-12
DD211714A5 (de) 1984-07-25
ES524909A0 (es) 1984-05-01

Similar Documents

Publication Publication Date Title
CH634334A5 (de) Neues glycoprotein und verfahren zu dessen herstellung.
EP0123307A2 (de) Gewebeprotein PP4, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2065867B2 (de) Carcinoembryonales Antigen und Verfahren zu seiner Gewinnung
US4383985A (en) Breast cancer antigens
EP0000134B1 (de) Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum
DE2126680B2 (de) Carcinoembryonales Antigen
EP0100522B1 (de) Neues Protein (PP17), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0101603B1 (de) Neues Protein (PP13), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0033000B1 (de) Neues Protein PP15, ein Verfahren zu seiner Herstellung sowie seine Verwendung
EP0014756B1 (de) Plazentaspezifisches Gewebsprotein PP10 und Verfahren zu seiner Anreicherung
Lospalluto et al. Chromatographic properties of gamma globulin: behavior of serum gamma macroglobulins
EP0037963B1 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0165476A2 (de) Gewebeprotein PP18, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0141326B1 (de) Neues Protein PP20, Verfahren zu seiner Gewinnung sowie seine Verwendung
EP0029191B1 (de) Neues Protein PP11, ein Verfahren zu seiner Gewinnung und seine Verwendung
DE2616984A1 (de) Verfahren zur anreicherung eines plazentenspezifischen glycoproteins
EP0102008A2 (de) Carcinoembryonales Antigen, Verfahren zu seiner Isolierung und seine Verwendung
DE3410694C2 (OSRAM)
EP0137345B1 (de) Membranassoziierte Proteine (MP2), Verfahren zu ihrer Gewinnung sowie ihre Verwendung
EP0151463B1 (de) Gewebeprotein PP19, Verfahren zu seiner Gewinnung sowie seine Verwendung
Bailey et al. Lipoprotein immunization and induced atherosclerosis in rabbits: Part 1. Cockerel beta-lipoproteins as antigens
EP0125514A2 (de) Membran-assoziiertes Plazentaprotein (MP1), Verfahren zu seiner Gewinnung sowie seine Verwendung
DE2445677A1 (de) Hochmolekulares alpha-globulin und verfahren zu dessen herstellung
Bloomfield et al. Some properties of transcobalamin III from normal human serum
Liewendahl Intracellular thyroxine-binding proteins in rabbit muscle and liver

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee